PANELLIST – Modulating the microbiome through the lifestages
13 February @ 15.35
Adam has over 20 years of industry experience in translational science, omics technologies, diagnostic development and clinical development in complex diseases with a particular focus on the gastro intestinal system. He currently leads a team who are responsible for the screening and research of current and next generation probiotics at Chr. Hansen. Prior to Chr. Hansen worked as the VP of Diagnostics Product Develop at Exiqon A/S in Denmark and the Head of New Technologies in deCODE Genetics in Iceland. Both of these roles focused on the development of new insights and therapeutics to support the treatment of complex diseases.